Various parts of the tumor microenvironment have therefore been inhibited with modest success in several trials.339,414 However, there are promising data for inhibition of the chemokine receptor CCR2 (C-C chemokine receptor type 2), which prevents PDAC-induced recruitment of MDSCs. The gene discussed is CCR2; the disease is neoplasm.